– Revenue Increased 7.7% to HK$ 429.6 Million – Profit Attributable to Equity Shareholders rose 20.0% to HK$115.0 Million -…
Browsing: HealthCare
HONG KONG, Nov 11, 2025 – (ACN Newswire) – Recently, the Bright China 2025 Clear Vision China Myopia Prevention and Control…
– These 52-week data reinforce HTD1801’s potential as a truly differentiated therapeutic to concurrently address metabolic dysregulation, inflammation, and renal…
Everest Medicines (HKG:1952) today announced that it has acquired an exclusive license with Visara, Inc. (Visara), a subsidiary of NovaBridge…
The 26th DCVMN Annual General Meeting, held in Bali on 29-31 October, marks a moment for Indonesia to reaffirm leadership…
HONG KONG, Oct 9, 2025 – (ACN Newswire) – Everest Medicines today announced that the results of its Asian multicenter Phase…
Hong Kong Department of Health accepts NDA for dorzagliatin, the world’s first approved glucokinase activator (GKA). Builds on China approval…
– Actively Advances Integration of ‘Technology+Innovation’ with Healthcare – New ‘Bamboos Health’ Ecosystem Covers the Full Lifecycle of ‘Prevention-Treatment-Rehabilitation-Home Care-Smart…
– The medical products maker hopes to leverage RWA technology to transform and leverage its current product infrastructure and budding…
HONG KONG, Sep 18, 2025 – (ACN Newswire) – CGSI reiterates the “Add” rating on Modern Dental (03600.HK) with a higher…
Nadzim Johan, Chief Activist of Muslim Consumers Association of Malaysia (Persatuan Pengguna Islam Malaysia or PPIM) (L) and Rajen Manickar,…
HONG KONG, Sep 17, 2025 – (ACN Newswire) – HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the…
HONG KONG, Sep 15, 2025 – (ACN Newswire) – Hong Kong’s healthcare sector surged by nearly 30% in the last decade,…
Company leverages dual-market strategy and technology-driven standardization to strengthen its leadership in China’s TCM sector and enter international markets. Sichuan…
Enabling clinicians to stay in flow-anytime, anywhere-with an intelligent, cloud-powered Enterprise Imaging Platform that is streaming-enabled, deeply integrated, and tailored…
On August 29, Everest Medicines (HKG: 1952) announced its interim results for the six months ended June 30, 2025. The…
– Continuous Enhancement of Operational Efficiency and Productivity under Accelerated Digitalization in Dentistry RESULTS HIGHLIGHTS: – The Revenue for the…
– Implementing ‘One Horizontal, One Vertical’ Strategy – AI Empowers Medical Institution Alliances to Strengthen New Quality Productive Forces HONG…
SHANGHAI, Aug 28, 2025 – (ACN Newswire) – Hua Medicine (the “Company”, HKEx: 2552) announced the unaudited consolidated results of the…
Agreement combines advanced TPU portfolio with Formerra’s expert compliance know-how and agile service. ROMEOVILLE, IL, Aug 27, 2025 – (ACN…